Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?

INTRODUCTION: Although intravenous immunoglobulin (IVIg) is commonly used in the clinic to treat various autoimmune and severe inflammatory diseases, the mode of action is not fully elucidated. This work investigates two proposed mechanisms: (1) the potential role of regulatory T‐cell epitopes (Treg...

Descripción completa

Detalles Bibliográficos
Autores principales: Sordé, Laetitia, Spindeldreher, Sebastian, Palmer, Ed, Karle, Anette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691310/
https://www.ncbi.nlm.nih.gov/pubmed/28560793
http://dx.doi.org/10.1002/iid3.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691310/
https://www.ncbi.nlm.nih.gov/pubmed/28560793
http://dx.doi.org/10.1002/iid3.167

Ejemplares similares